A Study of the Effect of Citrus aurantium L. Essential Oil on Anxiety and Its Interaction with GABAergic Pathways in Male Mice

Maryam Khosravi¹, Shahrzad Khakpour², Leila Adibi¹, Mahsa Hadipour Jahromy^2*

¹Biology Department, Faculty of Biological Sciences, Islamic Azad University North Tehran Branch, Tehran, Iran.
²Faculty of Medicine, Medical Sciences Research Center, Tehran Medical Branch, Islamic Azad University,Tehran, Iran.

DOI: 10.4236/jbbs.2014.410046                

Abstract

Anxiety is among the most common disorders affecting a great number of people. Different neurotransmitter systems, such as GABAergic system, play an important role in emergence of anxiety-related behaviors. In this study, we have investigated the effect of Citrus aurantium L. essential oil on anxiety and its interaction with GABAergic pathways. Male mice were assigned into control, sham, and experimental groups. Intraperitoneal injection of Citrus aurantium L. essential oil was applied at doses of 0.5, 2.5, and 5 percent for 5 days. Diazepam (0.1 mg/kg) was injected on the fifth day, thirty minutes before applying Citrus aurantium L. essential oil. The anxiety-related behavior of mice was then assessed using elevated plus-maze test. In groups receiving Citrus aurantium L. essential oil at doses of 2.5 and 5 percent, the percent time spent in the open arms increased significantly (P < 0.001). The injection of diazepam alone or with Citrus aurantium L. essential oil resulted in increasing in the number of entries to the open arms and the percent time spent in the open arms (P < 0.001). The results of this study show that Citrus aurantium L. essential oil can reduce anxiety-related behaviors in male mice thah may act via GABAergic system.

Keywords

Anxiety, Mice, Citrus aurantium L., Diazepam

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Andreasen, N.C. (2004) Acute and Delayed Posttraumatic Stress Disorder: A History and Some Issues. American Journal of Psychiatry, 161, 1321-1323. http://dx.doi.org/10.1176/appi.ajp.161.8.1321
[2]	Arrindell, W.A., Eisemann, M., Richter, J., et al. (2003) Phobic Anxiety in 11 Nations. Part1: Dimensional Constancy of the Five-Factor Model. Behaviour Research and Therapy, 41, 469-479.
[3]	Cohen, S.M.D. (1983) The Anxiolytic Agents. Drug Abuse and Alcoholism. Newsletter, 12, 1-4.
[4]	Mandrioli, R., Mercolini, L. and Raggi, M.A. (2008) Benzodiazepine Metabolism: An Analytical Perspective. Current Drug Metabolism, 9, 827-844. http://dx.doi.org/10.2174/138920008786049258
[5]	McKernan, R.M., Rosahl, T.W., Reynolds, D.S., Sur, C., Wafford, K.A., Atack, J.R., et al. (2000) Sedative But Not Anxiolytic Properties of Benzodiazepines Are Mediated by the GABAA Receptor Alpha (1) Subtype. Nature Neuroscience, 3, 587-592. http://dx.doi.org/10.1038/75761
[6]	Amravati, J. and Suryawanshi, S. (2011) An Overview of Citrus aurantium Used in Treatment of Various Diseases. African Journal of Plant Science, 5, 390-395.
[7]	Carvalho-Freitas, M.I. and Costa, M. (2002) Anxiolytic and Sedative Effects of Extracts and Essential Oil from Citrus aurantium L. Biological and Pharmaceutical Bulletin, 25, 1629-1633.
[8]	Colker, C.M., Kalman, D.S., Torina, G.C., Perlis, T. and Street, C. (1999) Effects of Citrusaurantium Extract, Caffeine, and St. John’s Wort on Body Fat Loss, Lipid Levels, and Moodstates in Overweight Healthy Adults. Current Therapeutic Research, 60, 145-153. http://dx.doi.org/10.1016/S0011-393X(00)88523-9
[9]	Re, L., Barocci, S., Sonnino, S., et al. (2000) Linalool Modifies the Nicotinic Receptor-Ionchannel Kinetics at the Mouse Neuromuscular Junction. Pharmacological Research, 42, 177-181. http://dx.doi.org/10.1006/phrs.2000.0671
[10]	Silva Brum, L.F., Emanuelli, T., Souza, D.O., et al. (2001) Effects of Linalool on Glutamaterelease and Uptake in Mouse Cortical Synaptosomes. Neurochemical Research, 26, 191-194. http://dx.doi.org/10.1023/A:1010904214482
[11]	Deckers, C.L.P., Genton, P., Sills, G.J. and Schmidt, D. (3003) Current limitations of Antiepileptic Drug Therapy: A Conference Review. Epilepsy Research, 53, 1-17. http://dx.doi.org/10.1016/S0920-1211(02)00257-7
[12]	Johnston, G.A.R. (2005) GABAA Receptor Channel Pharmacology. Current Pharmaceutical Design, 11, 1867-1885. http://dx.doi.org/10.2174/1381612054021024
[13]	Marder, M., Estiú, G., Bruno Blanch, L., et al. (2001) Molecular Modeling and QSAR Analysis of the Interaction of Flavone Derivatives with the Benzodiazepine Binding Site of the GABAA Receptor Complex. Bioorganic & Medicinal Chemistry, 9, 323-335. http://dx.doi.org/10.1016/S0968-0896(00)00250-9
[14]	Shen, D.W., Higgs, M.H., Salvay, D., Olney, J.W., Lukasiewicz, P.D. and Romano, C. (2002) Morphological and Electrophysiological Evidence for an Ionotropic GABA Receptor of Novel Pharmacology. Journal of Neurophysiology, 87, 250-256.
[15]	Shabanian, Gh., Pourya, M.E. and Akhlaghi, M. (1387) The Effect of Citrus aurantium and Diazepam on Reducing Anxiety before Surgery. Journal of Shahrekord University of Medical Sciences, 4, 13-18.